错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Clinical Trials in Developing Countries: Achievements and Challenges

  • Yaser Mohammed Al-Worafi

摘要

Clinical trials in developing countries have gained significant attention due to their potential to address local health needs, improve healthcare access, and contribute to medical advancements. However, these trials also face numerous challenges that need to be effectively addressed. This chapter provides an overview of the challenges, recommendations, and importance of conducting clinical trials in developing countries. The challenges faced in conducting clinical trials in developing countries include regulatory and ethical considerations, limited research capacity and infrastructure, access to healthcare, socio-cultural factors, and financial constraints. To overcome these challenges, several recommendations have been put forth. Strengthening regulatory frameworks, building research capacity, promoting community engagement, addressing health disparities, and fostering sustainable collaborations are among the key recommendations. These efforts aim to ensure ethical conduct, enhance local research capabilities, engage communities, and promote equitable participation in clinical trials. Conducting clinical trials in developing countries is of paramount importance. These trials provide opportunities for improving healthcare access, developing localized treatment guidelines, addressing prevalent diseases, and advancing medical knowledge. They also contribute to capacity building, economic development, and global health equity. Through collaboration, knowledge sharing, and adherence to ethical practices, clinical trials in developing countries can yield valuable data, drive evidence-based healthcare decisions, and ultimately improve the health outcomes of the population. In conclusion, clinical trials in developing countries offer immense potential for addressing local health challenges and advancing medical knowledge. While challenges exist, implementing the recommended strategies can mitigate these barriers and enhance the conduct and impact of clinical trials. By prioritizing ethical considerations, capacity building, community engagement, and collaborative partnerships, clinical trials in developing countries can generate reliable evidence, improve healthcare access, and contribute to the overall well-being of the population.